High-density lipoprotein cholesterol is positively associated with hypertension in apparently healthy Japanese men and women

British Journal of Biomedical Science

Volumn 68, Issue 1, 2011, Pages 29-33

  Oda, Eiji ^a   Kawai, R ^a  

^a Tachikawa Medical Center   (Japan)

Author keywords

Blood pressure; Cholesterol, HDL; Hypertension; Metabolic syndrome

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY FAT; BODY MASS; CARDIOVASCULAR RISK; CLINICAL EVALUATION; CORRELATION COEFFICIENT; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE CONTROL; DRINKING BEHAVIOR; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; JAPANESE; MALE; METABOLIC DISORDER; NORMAL HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; SYSTOLIC BLOOD PRESSURE;

EID: 80051696806     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2011.11732838     Document Type: Article

References (29)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607. (Pubitemid 19004941)
2. World Health Organization. Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO Consultation. Geneva: WHO, 1999.
3. Expert Panel on the Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
4. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: a statement for health care professionals: an American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-52. (Pubitemid 41532612)
5. Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome - a new worldwide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-80.
6. Alberti KGMM, Eckel RH, Grundy SM et al. Harmonizing the metabolic syndrome. A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-5.
7. Oda E. The metabolic syndrome as a concept of adipose tissue disease. Hypertens Res 2008; 31: 1283-91.
8. Ridker PM, Wilson PWF, Grandy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004; 109: 2818-25. (Pubitemid 38780294)
9. Oda E, Oohara K, Abe A et al. The optimal cut-off point of C-reactive protein as an optional component of metabolic syndrome in Japan. Ci'rc J 2006; 70: 384-8.
10. Oda E, Kawai R. Very low levels of high-sensitivity C-reactive protein are not bimodally distributed but are significantly related to other metabolic risk factors in Japanese. Intern Med 2009; 48: 953-8.
11. Oda E, Kawai R. Tentative cut-off point of high-sensitivity C-reactive protein for a component of metabolic syndrome in Japanese. Circ J 2009; 73: 755-9.
12. Oda E, Kawai R. Reproducibility of high-sensitivity C-reactive protein as an inflammatory component of metabolic syndrome in Japanese. Circ J 2010; 74: 1488-93.
13. Kotronen A, Yki-Järvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008; 28: 27-38.
14. Oda E, Kawai R, Sukumaran V, Watanabe K. LDL cholesterol is more strongly associated with metabolic syndrome in Japanese women than in men. Intern Med 2009; 48; 1607-14.
15. Oda E, Kawai R. Uric acid is positively associated with metabolic syndrome but negatively associated with diabetes in Japanese men. Intern Med 2009; 48; 1607-14.
16. Oda E, Kawai R. A cross-sectional relationship between vital capacity and diabetes in Japanese men. Diabetes Res Clin Pract 2009; 85: 111-6.
17. Oda E, Kawai R. Low vital capacity is associated with diabetes despite inverse relationships with metabolic risk factors in lean Japanese men. Intern Med 2009; 48: 1201-7.
18. Oda E, Kawai R. Significance of heart rate on the prevalence of metabolic syndrome and its related risk factors in Japanese. Circ J 2009; 73: 1431-6.
19. Oda E, Kawai R, Watanabe, K, Sukumaran V. Prevalence of metabolic syndrome increases with the increase in blood levels of gamma glutamyltransferase and alanine aminotransferase in Japanese men and women. Intern Med 2009; 48: 1343-50.
20. Halperin RO, Sesso HD, Ma J, Buring JE, Stampfer MJ, Gaziano JM. Dyslipidemia and the risk of incident hypertension in men. Hypertension 2006; 47: 45-50. (Pubitemid 43177814)
21. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes and inflammation. Circulation 2005; 111: 1448-54. (Pubitemid 40396812)
22. Kim J, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction. Molecular and pathophysiological mechanisms. Circulation 2006; 113: 1888-904. (Pubitemid 43739401)
23. Katagiri H, Yamada T, Oka Y. Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals. Circ Res 2007; 101: 27-39. (Pubitemid 47094621)
24. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM. Insulin resistance and cigarette smoking. Lancet 1992; 339: 1128-30.
25. Farin HM, Abbasi F, Kim SH, Lamendola C, McLaughlin T, Reaven GM. The relationship between insulin resistance and dyslipidaemia in cigarette smokers. Diabetes Obes Metab 2007; 9: 65-9. (Pubitemid 44921043)
26. Gaziano JM, Buring JE, Breslow JL et al. Moderate alcohol intake increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med 1993; 329: 1829-34. (Pubitemid 23360481)
27. Fuchs FD, Chambless LE, Whelton PK, Nieto FJ, Heiss G. Alcohol consumption and the incidence of hypertension: The Atherosclerosis Risk in the Communities Study. Hypertension 2001; 37: 1242-50. (Pubitemid 34163576)
28. Sesso HD, Cook NR, Buring JE, Manson JE, Gaziano JM. Alcohol consumption and the risk of hypertension in women and men. Hypertension 2008; 51: 1080-7. (Pubitemid 351398961)
29. Barter PJ, Caulfield M, Eriksson M et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 2007; 357: 2109-22. (Pubitemid 350146106)